Skip to content

Central Alberta to soon get new hand-held virus tests for quicker results

AHS has formed a partnership with Spartan BioScience to develop the devices
21123071_web1_200330-RDA-faster-test-test_2
Hand-held virus testing devices are being made by Spartan BioScience in partnership with Alberta Health Services. AHS expects to soon have 250 of these for quick testing, without the use of a lab. (Contributed photo).

Central Albertans will soon have fast, convenient access to COVID-19 testing.

Alberta Health Services announced on Monday that a hand-held device to support COVID-19 testing in rural and remote communities is in the final stages of development by Spartan Bioscience Inc., a Canadian technological company.

The device can confirm test results in less than an hour — and the technology is expected to help AHS provide additional, quicker testing for the new coronavirus in rural centres, as well as remote Indigenous communities.

AHS says testing device will eliminate the need for lab samples to travel to the nearest laboratory, which can be a logistical challenge.

As part of a $9.5-million contract, AHS will receive 250 hand-held devices, along with 100,000 testing kits.

These will be distributed to health-care facilities outside of Calgary and Edmonton. The first shipment of devices and testing kits arrives next month. But AHS hasn’t determined yet which communities will receive them.

Health Canada is expected to approve the use of the rapid test kits within a few weeks. AHS will validate test protocols and accuracy before the new technology is deployed, but has acted quickly to ensure the test kits are available in the province once approval is received.

“Alberta has been one of the fastest jurisdictions in the world for testing of COVID-19. However … we have recognized a gap in our testing, and I am pleased AHS is working swiftly with industry to find ways to ensure rapid testing for the virus is accessible for people in rural and remote communities,” says Health Minister Tyler Shandro.

“This investment will … alleviate pressures on our front-line workers with quick result confirmations.”

The technology will be used in addition to AHS’s current lab testing.

“COVID-19 places significantly increased demand on our lab capacity. (The new testing devices) will help guide appropriate care and isolation, speed up our contact tracing, and reduce the risk of further spread,” says AHS president and CEO Dr. Verna Yiu.